Improving the understanding of cancer mutations using advanced statistical methods
Utilizing Bayesian modeling to improve mutational signature inference in large-scale datasets
['FUNDING_U01'] · BOSTON UNIVERSITY MEDICAL CAMPUS · NIH-10684720
This study is working on new ways to understand the patterns of mutations in cancer samples, which can help researchers figure out how different types of cancer develop, and it will also create user-friendly software so that anyone can use these tools, even if they aren't computer experts.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY MEDICAL CAMPUS (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10684720 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new statistical methods and software tools to analyze mutational signatures in cancer samples. Mutational signatures are patterns of mutations that provide insights into how cancer develops and evolves. The project aims to create a Bayesian hierarchical model that addresses the limitations of current methods, allowing for better prediction and classification of cancer types based on their mutation profiles. Additionally, an interactive software interface will be developed to make this analysis accessible to researchers without computational expertise.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who are interested in understanding the genetic factors contributing to their disease.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and personalized treatment strategies based on mutational profiles.
How similar studies have performed: Previous research has shown promise in using advanced statistical models for cancer mutation analysis, indicating that this approach could yield significant advancements.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY MEDICAL CAMPUS — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CAMPBELL, JOSHUA D — BOSTON UNIVERSITY MEDICAL CAMPUS
- Study coordinator: CAMPBELL, JOSHUA D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, Cancer Causing Agents